Thursday, December 27, 2018

BioXcel Therapeutics (BTAI) Granted FDA Fast Track Designation for BXCL501 for Acute Treatment of Agitation - https://t.co/gM21sWBOiB https://t.co/CW572zIYHO


from Twitter https://twitter.com/IDROOhio

December 27, 2018 at 11:45AM

No comments:

Post a Comment